CSIMarket
 


Dice Therapeutics Inc   (DICE)
Other Ticker:  
 

Dice Therapeutics Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Dice Therapeutics Inc in the second quarter 2023?
Dice Therapeutics Inc recorded a cumulative net loss of $-104 million during 12 months ending in the second quarter 2023, resulting in a negative return on equity (ROE) of -22.01%.

Within the Major Pharmaceutical Preparations industry 105 other companies had a higher return on equity. While Return on equity, overall ranking has advanced in the quarter, so far to 2853, from total ROE ranking in the first quarter 2023 at 2911.

What is ROE?



Return On Equity (Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
Y / Y Equity Change 86.75 % 85.29 % 81.18 % -20.28 % -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -104 -91 -84 -43 -40
Return On Equity (TTM) -22.01 % -22.01 % -23.95 % -15.11 % -13.22 %
DICE's Total Ranking # 2853 # 2911 # 3352 # 2873 # 3040
Equity (TTM) in Millions 519 547 567 261 278
Seq. Equity Change -5.09 % -3.54 % 117.14 % -6.05 % -5.84 %
Seq. Net Income Change - - - - -

Return On Equity Company Ranking
Within: No.
Industry # 106
Sector # 287
Overall # 2853

Return On Equity Statistics
High Average Low
-13.22 %
-19.26 %
-23.95 %
(Jun 30 2022)   (Dec 31 2022)





DICE Annual Return On Equity (Dec 31 2022)
2022
(Dec 31 2021)
2021



Total Equity in Millions 567 313 0 0 0
Y / Y Equity Change 81.18 % - - - -
Net Income in Millions -84 -49 0 0 0
Y / Y Net Income Change - - - - -
Return On Equity -14.8 % -15.64 % - - -





More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
DICE's' Return on Equity at Yahoo Finance
DICE's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Roe for DICE's Competitors
Return On Equity for Dice Therapeutics Inc 's Suppliers
Roe for DICE's Customers




Companies with similar Return On Equity at Jun 30 2023, within Healthcare Sector ROE


Date modified: 2023-08-09T20:14:59+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com